Androgen deprivation therapy: minimizing exposure and mitigating side effects.

Area of Science:

• Oncology
• Urology

Background:

• Androgen deprivation therapy (ADT) is a cornerstone in prostate cancer management.
• Its use is widespread across all disease stages and presentations.
• However, ADT is associated with significant side effects and is sometimes employed in situations lacking strong evidence of benefit.

Purpose of the Study:

• To evaluate the current role and indications for ADT in prostate cancer.
• To discuss the impact of evolving treatment modalities on ADT utilization.
• To emphasize strategies for optimizing patient selection and mitigating side effects.

Main Methods:

• Review of current clinical practices and evidence regarding ADT in prostate cancer.
• Analysis of the evolving landscape of prostate cancer treatment, including advanced radiotherapy techniques.
• Discussion of patient education and side effect management strategies.

Main Results:

• ADT is frequently used in scenarios with limited evidence of benefit, such as favorable-risk disease or in elderly patients with low-risk prostate cancer.
• The importance of ADT is diminishing in intermediate- and high-risk disease due to advancements in radiotherapy (external beam and brachytherapy).
• Careful patient selection based on established indications is crucial to minimize exposure.

Conclusions:

• Optimizing patient selection for ADT is essential to reduce unnecessary exposure.
• Systematic patient education prior to treatment can help manage and ameliorate side effects.
• Minimizing ADT exposure and effectively mitigating its side effects can significantly improve the quality of life for men with prostate cancer.